Loading…
Evolent Health, Inc. is projected to rise to $3.44 by 2027, a +11% move from its current price of $3.09. EVH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $2.94 | $3.09 | $3.26 | +0.13% |
| Aug 4 | $2.88 | $3.10 | $3.34 | +0.25% |
| Aug 5 | $2.83 | $3.10 | $3.40 | +0.38% |
| Aug 6 | $2.80 | $3.11 | $3.45 | +0.51% |
| Aug 7 | $2.77 | $3.11 | $3.50 | +0.64% |
| Aug 8 | $2.74 | $3.11 | $3.54 | +0.77% |
| Aug 9 | $2.71 | $3.12 | $3.58 | +0.90% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.71 | $3.12 | $3.58 | +0.90% |
| Week 2 | $2.59 | $3.15 | $3.83 | +1.80% |
| Week 3 | $2.50 | $3.17 | $4.03 | +2.71% |
| Week 4 | $2.43 | $3.20 | $4.23 | +3.63% |
| Week 5 | $2.37 | $3.23 | $4.40 | +4.56% |
| Week 6 | $2.32 | $3.26 | $4.58 | +5.49% |
| Week 7 | $2.28 | $3.29 | $4.75 | +6.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
The company offers an integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management.
Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, and Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests, are part of its offerings. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
EVH is a healthcare stock trading at $3.30, with a market capitalization of $371.19M, and a rank of 3282.
The current price action is shaped by neutral technicals, including RSI(14) at 30, with moving averages at SMA50 $4.79 and SMA200 $4.18. Support is identified at $3.30 and resistance at $6.19.
The 30-day price range spans $2.30 to $4.74, reflecting near-term volatility, and the stock carries an annualized volatility of 100%.
Forecasts imply a flat start in 2026 with min $2.17, avg $3.30, max $4.84 and ROI 0, followed by a path of rising potential and a shift to bullish momentum in later years, beginning from 2031 onward.
A major floor 66.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 100.3% above — a clean break opens room to run.
A major ceiling 133.8% above — clearing it would confirm fresh momentum.
Key EVH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EVH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.42 | Sell | $3.50 | Sell |
| MA 10 | $4.33 | Sell | $4.07 | Sell |
| MA 20 | $5.06 | Sell | $4.58 | Sell |
| MA 50 | $4.76 | Sell | $4.63 | Sell |
| MA 100 | $3.92 | Sell | $4.41 | Sell |
| MA 200 | $4.14 | Sell | $5.09 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 23.96 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -139.25 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.34 | Sell |
| ROC (12) | -47.36 | Sell |
| Bollinger %B (20,2) | 0.03 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.24 | Sell |
| Awesome (5,34) | -1.63 | Sell |
| Ultimate (7,14,28) | 9.53 | Buy |
| Momentum (10) | -2.72 | Sell |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 2.82 | Buy |
| ADX (14) | 33.45 | Sell |
| ATR (14) | 0.24 | Info |
The near-term technical picture is NEUTRAL, with RSI(14) at 30 and the price holding near the $3.30 support.
The stock trades below the SMA50 of $4.79 and the SMA200 of $4.18, suggesting limited upside in the immediate horizon and a resistance at $6.19.
The 30-day range is $2.30 to $4.74, illustrating modest volatility around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.17 | $3.09 | $4.49 | 0% | Neutral | |
| $2.52 | $3.44 | $5.09 | +11% | Neutral | |
| $2.52 | $3.65 | $5.76 | +18% | Neutral | |
| $2.36 | $3.60 | $5.96 | +17% | Neutral | |
| $2.15 | $3.44 | $5.91 | +11% | Neutral | |
| $2.45 | $4.10 | $7.30 | +33% | Bullish | |
| $3.04 | $5.30 | $9.74 | +72% | Bullish | |
| $3.54 | $6.42 | $12.11 | +108% | Bullish | |
| $3.33 | $6.27 | $12.13 | +103% | Bullish | |
| $2.85 | $5.57 | $11.02 | +80% | Bullish | |
| $4.41 | $9.81 | $21.32 | +217% | Bullish | |
| $6.45 | $14.33 | $32.96 | +364% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.17 | $3.09 | $3.88 | +0.00% |
| September 2026 | $2.78 | $3.37 | $4.28 | +9.18% |
| October 2026 | $2.82 | $3.47 | $4.49 | +2.86% |
| November 2026 | $2.68 | $3.34 | $4.39 | -3.65% |
| December 2026 | $2.68 | $3.37 | $4.49 | +0.79% |
Click any year to see its month-by-month EVH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The EVH price prediction for 2026 points to an average of $3.09 (low $2.17, high $4.49) — a potential gain of 0% on today's $3.09. Price action looks broadly range-bound.
In 2027, EVH is projected to trade between $2.52 and $5.09, averaging $3.44 — a potential gain of +11% from today's $3.09. That is up +11% on the projected 2026 average. A consolidation phase looks the most probable path here.
Evolent Health, Inc.'s 2028 outlook centres on $3.65, within a $2.52 to $5.76 range. That is up +6% on the projected 2027 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2029, EVH could reach as high as $5.96, with a base case around $3.60 and support toward $2.36 — roughly +17% from $3.09. A consolidation phase looks the most probable path here.
Expect EVH to range from $2.15 to $5.91 through 2030. The $3.44 average target implies a +11% move from current prices. That is -5% versus the projected 2029 average. Price action looks broadly range-bound.
The EVH price prediction for 2031 points to an average of $4.10 (low $2.45, high $7.30) — a potential gain of +33% on today's $3.09. Buyers look set to stay in control over this stretch.
In 2032, EVH is projected to trade between $3.04 and $9.74, averaging $5.30 — a potential gain of +72% from today's $3.09. That is up +29% on the projected 2031 average. Momentum favours further upside here.
Evolent Health, Inc.'s 2033 outlook centres on $6.42, within a $3.54 to $12.11 range. That is up +21% on the projected 2032 average. That marks a +108% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, EVH could reach as high as $12.13, with a base case around $6.27 and support toward $3.33 — roughly +103% from $3.09. Momentum favours further upside here.
Expect EVH to range from $2.85 to $11.02 through 2035. The $5.57 average target implies a +80% move from current prices. That is -11% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The EVH price prediction for 2040 points to an average of $9.81 (low $4.41, high $21.32) — a potential gain of +217% on today's $3.09. Momentum favours further upside here.
In 2050, EVH is projected to trade between $6.45 and $32.96, averaging $14.33 — a potential gain of +364% from today's $3.09. That is up +46% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in EVH today (≈ 323.624595 EVH) could be worth
$4,638.04
+$3,638.04 (+364%) by 2050 · US Dollar
Based on the average projected EVH price of $14.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EVHwould be worth at today's price.
$1,000 invested in EVH on Jul 31, 2025 (≈ 99.502486 EVH) would be worth
$307.46
-$692.54 (-69.3%) today · 0.31× · US Dollar
Based on a EVH entry price of $10.05 vs. today's $3.09.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.22 | $732.23 | -26.8% |
| 1 month ago | $5.74 | $538.33 | -46.2% |
| 3 months ago | $3.75 | $824 | -17.6% |
| 6 months ago | $3.26 | $947.85 | -5.2% |
| 1 year ago | $10.05 | $307.46 | -69.3% |
| All time (5.0y) ago | $23.08 | $133.88 | -86.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EVH forecast.
Our base-case forecast reaches $6.20 around 2033.
Implied market cap at $6.20: $697.38M
The multi-year forecast shows a progression from near-term neutrality to longer-term upside. In 2030, the average price is forecast at $3.59 with min $2.23 and max $6.22, and ROI 8.8%; sentiment is NEUTRAL.
From 2031 onward, sentiment shifts to BULLISH, with 2031 avg $4.31, max $7.73 and ROI 30.6%; 2032 avg $5.70, max $10.54 and ROI 72.6%; 2033 avg $6.84, max $13.00 and ROI 107.2%; 2034 avg $6.63, max $12.92 and ROI 100.9%; 2035 avg $5.91, max $11.79 and ROI 79.
The 2040 forecast shows min $4.69, avg $10.42, max $22.85 with ROI 215.7% and remains BULLISH, while 2050 projects min $6.81, avg $15.12, max $34.78 with ROI 358.3% and remains BULLISH. These figures are estimates and carry uncertainty.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $3.59, with a range of $2.23 to $6.22 and ROI 8.8%; sentiment NEUTRAL.
The near-term forecast is NEUTRAL for 2026 (min $2.17, avg $3.30, max $4.84, ROI 0). Longer term, 2031–2050 turns BULLISH, with higher expected averages and ROIs, but these are estimates, not guarantees.
Yes. The 2032 forecast max is $10.54; the 2040 forecast max is $22.85, indicating potential upside beyond $10, depending on the year.
Current price is $3.30 and market capitalization is $371.19M.
The 30-day range is $2.30 to $4.74.
Evolent Health, Inc. Community Discussion
0Share your Evolent Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.